SCHEMBL14616507

SCHEMBL14616507

CC(=O)Cc1c(C)cc(C)c(-c2ccc(Cl)cc2)c1C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 7/20 0.38
RAB9A P51151 4/20 0.36
KDM4E B2RXH2 4/20 0.36
PPARG P37231 1/20 0.35
PPARD Q03181 1/20 0.35
PPARA Q07869 1/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
KMT2A Q03164 1/20 0.35
NPC1 O15118 3/20 0.35
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
TP53 P04637 1/20 0.34
MDM2 Q00987 1/20 0.34
PRKCZ Q05513 1/20 0.34
CA12 O43570 1/20 0.34
CA9 Q16790 1/20 0.34
CHRNA7 P36544 1/20 0.33
POLB P06746 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14089360 0.88 PTGDR2 (0.38) PTGDR2RAB9AKDM4EPPARGPPARD
SCHEMBL14089366 0.84 KDM4E (0.44) KDM4EMEN1ALDH1A1KMT2ATDP1
SCHEMBL14616506 0.77 PTGDR2 (0.38) PTGDR2RAB9AKDM4EMEN1ALDH1A1
SCHEMBL31236754 0.76 P2RX7 (0.35) KDM4EMEN1ALDH1A1KMT2ATP53
SCHEMBL31236753 0.76 P2RX7 (0.35) KDM4EMEN1ALDH1A1KMT2ATP53
SCHEMBL14616505 0.71 SUCNR1 (0.43) PTGDR2RAB9AKDM4EMEN1ALDH1A1
SCHEMBL10863121 0.68 PGK1 (0.39) KDM4EALDH1A1POLBMAPT
SCHEMBL17043261 0.68 CCNB2 (0.37) MEN1ALDH1A1KMT2ANPC1TP53
SCHEMBL812155 0.68 SHMT1 (0.39) PTGDR2RAB9AKDM4EPPARDMEN1
SCHEMBL812156 0.68 PTGDR2 (0.47) PTGDR2KDM4EPPARDMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130018202-A1 4-Biphenyl-Substituted Pyrazolidin-3,5-Dione Derivatives BAYER CROPSCIENCE AG (DE) 2013-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130018202-A1 4-Biphenyl-Substituted Pyrazolidin-3,5-Dione Derivatives DDT, CYP4X1, HPD PTGDR2 1744/4885RAB9A 2106/4885KDM4E 497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.